id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
admet-276	Wan, Hong	An Overall Comparison of Small Molecules and Large Biologics in ADME Testing	2016	22	.pdf	application/pdf	12641	722	50	General non-clinical safety evaluations of biologics in particular for ADC drugs are outlined including drug-drug interaction (DDI) and metabolite/catabolite assessments. Hence, drug metabolite and DDI should be concerned for ADC drugs, but maybe not for mAbs wherein the DDI risk is presumably low or not as prominent as small molecules.	cache/admet-276.pdf	txt/admet-276.txt